Changing Patterns of Resistance to New Beta-Lactarn Antibiotics
- 1 July 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (1) , 29-34
- https://doi.org/10.1016/s0002-9343(84)80093-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporinAntimicrobial Agents and Chemotherapy, 1980
- In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1979
- Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activitiesAntimicrobial Agents and Chemotherapy, 1979
- Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine CephalosporinAntimicrobial Agents and Chemotherapy, 1979
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and CefoxitinAntimicrobial Agents and Chemotherapy, 1978
- Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitroJournal of Antimicrobial Chemotherapy, 1978
- Activity of HR 756 against Haemophilus influenzae, Barteroides fragilis and Gram-negative rodsJournal of Antimicrobial Chemotherapy, 1978
- Experimental evaluation of HR 756, a new cephalosporin derivative: Pre-clinical studyInfection, 1977